Analyzing the expression of BDNF-AS in primary and recurrent LGG (Figure 5D) and GBM (Figure 5E) tumors demonstrated a significant decrease in both types of recurrent tumors (p < 0.01 for GBM and p < 0.001 for LGG). Here, BDNF is linked to glioblastoma.